ImmuLogic Pharmaceutical Corp. has filed an investigationalnew drug (IND) application with FDA for Allervax Ragweed.The allergy therapeutic, for treatment of people allergic toragweed, will be the company's second allergy therapeutic toenter clinicals.
Allervax Cat, a vaccine for people who are allergic to cats, is inPhase II testing. Other Allervax vaccines in development aretargeted to allergens for house-dust mites, Japanese cedarpollen and grass pollens. ImmuLogic (NASDAQ:IMUL) ofWaltham, Mass., is developing its Allervax line with partnerMarion Merrell Dow Inc.
(c) 1997 American Health Consultants. All rights reserved.